Abstract The central nervous system (CNS) is a large network of intercommunicating cells that function to maintain tissue health and homeostasis. Considerable evidence suggests that glucocorticoids exert both neuroprotective and neurodegenerative effects on the CNS. Glucocorticoids act by binding two related receptors in the cytoplasm, the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). The glucocorticoid receptor complex mediates cellular responses by transactivating target genes and by protein: protein interactions. The paradoxical effects of glucocorticoids on neuronal survival and death have been attributed to the concentration and the ratio of mineralocorticoid to glucocorticoid receptor activation. Glucocorticoid-induced leucine zipper (GILZ) is a recently identified protein transcriptionally upregulated by glucocorticoids. Constitutively, expressed in many tissues including brain, GILZ mediates many of the actions of glucocorticoids. It mimics the anti-inflammatory and antiproliferative effects of glucocorticoids but exerts differential effects on stem cell differentiation and lineage development. Recent experimental data on the effects of GILZ following induced stress or trauma suggest potential roles in CNS diseases. Here, we provide a short overview of the role of GILZ in CNS health and discuss three potential rationales for the role of GILZ in Alzheimer's disease pathogenesis.
Introduction Glucocorticoids in the Central Nervous System
Glucocorticoids (corticosterone in rodents and cortisol in humans) secreted in response to stress-induced activation of the hypothalamo-pituitary-adrenal (HPA) axis exert a wide range of actions on most cell types including the cells of the central nervous system (CNS) [1, 2] . Upon binding the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR) in the cytoplasm, the glucocorticoid receptor complex translocate to the nucleus and mediates cellular responses by genomic mechanisms via specific glucocorticoid response elements (GRE) in the DNA or by non-genomic protein: protein interactions. The receptors shuttle between the cytoplasm and the nucleus; their subcellular localization being determined by the equilibrium between nuclear import and export [3] . The negative feedback and circadian rhythmicity of circulating glucocorticoids are critical for maintaining the basal HPA axis activity and facilitate the termination of stress-induced HPA activation [3, 4] .
Glucocorticoids exhibit tenfold higher affinity for MR than GR [5, 6] . In the CNS, the glucocorticoids/two receptor systems work in balance, modulating a large spectrum of actions. While MR is highly expressed in limbic areas such as the hippocampus and amygdala, GR is ubiquitously expressed throughout the brain [7, 8] . Sensitivity to glucocorticoids depends on the concentration and duration of exposure, bioavailability, and the density of receptors. In physiological conditions and during circadian trough, the high-affinity MR is preferably occupied with less than 10% GR occupancy to help maintain low basal glucocorticoid levels [3, 9] . Several studies suggest that the MR functionality is important for maintaining the basal HPA activity and preserving the normal metabolism of the neurons [10, 11] . Pathological effects of glucocorticoids are largely mediated by GR. While both receptors can modulate transcription of the same target genes, microarray studies suggest that approximately 20% of the expression profiles are uniquely modulated by GR [12] . This is largely attributed to the non-genomic functions, wherein nuclear GR tethers to and interferes with the functioning of other transcription factors such as nuclear factor-kappa B (NF-κΒ) and activator protein-1 (AP-1) [8, 13] .
Glucocorticoids in Alzheimer's Disease
Both lack and overexposure of glucocorticoids increase the risk for neurodegenerative diseases. Excessive glucocorticoid alters MR/GR ratio, disrupts nucleocytoplasmic shuttling of glucocorticoid receptors, and dysregulates HPA activity [1, 4] . Clinical observations of elevated plasma cortisol and/or changes in the circadian rhythm of glucocorticoid release in Alzheimer's disease (AD) and Parkinson's disease (PD) support a role for high GC in neurodegenerative pathologies [14] [15] [16] . In AD patients, the higher plasma glucocorticoids correlated with decreased volume of the hippocampus, a region of the brain critical for learning and memory [15, 16] . Mechanistically, highly elevated glucocorticoids accelerated beta amyloid (Aβ) plaque formation and tau phosphorylation increasing the vulnerability of neuronal cells to apoptosis [17] . In a triple transgenic mouse model of AD that develops both Aβ and tau pathologies in a progressive and region-specific manner, dexamethasone (a glucocorticoid) treatment upregulated steady-state levels of amyloid precursor protein (APP), β-site APP cleaving enzyme (BACE1), and enhanced Aβ generation [18, 19] . Blockade of glucocorticoid/GR but not glucocorticoid/MR interaction abrogated the dexamethasonemediated upregulation of Aβ secretion [20] .
Both stress and aggregates of Aβ upregulate generation of reactive oxygen species in vulnerable neurons and precipitate oxidative stress, considered an early pathological event in AD [21, 22] . Chronic stress increased lipid peroxidation in the hippocampus in normal and transgenic AD mice with threefold higher upregulation in the transgenic animals [23] . Oxidative stress has been shown to mediate negative regulation of GR and allow retention of the glucocorticoid:GR complex in the cytoplasm [23, 24] . This reduces the ability of glucocorticoids to repress transcriptional factors NF-κΒ and AP-1, leading to inflammatory distress. Increased oxidative stress further enhances Aβ accumulation initiating a vicious cycle [21] . In transgenic AD mice, this Aβ-induced oxidative stress could be suppressed by pharmacological blockade of corticosterone release suggesting that the elevated glucocorticoids and Aβ act synergistically to enhance the vulnerability of neurons to apoptosis [20] .
Glucocorticoid-Induced Leucine Zipper
Glucocorticoid-induced leucine zipper (GILZ) is a recently identified protein that mediates many of the cellular effects of glucocorticoids. It is a member of the TSC22D (transforming growth factor β1-stimulated clone 22 domain) family of proteins that potentially impact multiple biological processes [25, 26] . Four different isoforms of GILZ that arise from splice variants of a single gene are identified [27, 28] . The GILZ protein has an amino terminal leucine zipper motif for dimerizing and a carboxy terminal proline rich region for protein-protein interactions [25, 26] . Constitutive expression of GILZ has been reported in many cell types and multiple organs including skeletal muscle, lungs, intestine, kidney, and brain [25, 27] . With six GRE in its promoter region, GILZ is strongly induced by glucocorticoids [25] . Much like other glucocorticoid responsive genes, such as tyrosine aminotransferase (TAT), glutamine synthetase, cholesterol-7α-hydroxylase, and GR, GILZ exhibits circadian expression in response to the rhythmic release of endogenous glucocorticoid [27] .
GILZ in the CNS
Endogenous GILZ is widely expressed throughout the brain and the spinal cord suggesting a physiological role in CNS health [27] . In mice exposed to water immersion restraint stress, activation of HPA activity and increased glucocorticoid secretion correlated with elevated GILZ expression in medial prefrontal cortex and hippocampal neurons [29, 30] . Stressinduced GILZ upregulation was abrogated in adrenalectomized mice attributing the response to increase in glucocorticod GRmediated transactivation [30] . Constitutive expression of GILZ has been observed in murine microglial cells. Further, similar to the observations in macrophages and lymphocytes, microglial GILZ expression correlated negatively with inflammatory cytokines and was downregulated following induced anxiety [29, 31] .
Plausible Roles of GILZ in AD
Three distinct rationales are postulated for potential roles of GILZ in AD pathogenesis. (1) A role in Aβ regulation supported by the ubiquitous expression of GILZ in neurons and glia [27, 30] , (2) a role in neurogenesis based on potential cross-talk between GILZ and NF-κβ as well as other nuclear transcriptional hormone receptors such as peroxisome proliferatoractivated receptor (PPAR)-γ and CCAAT/enhancer-binding protein (C/EBP)-δ [32] , and (3) a role for GILZ as an antiinflammatory molecule that modulates the processes of neuroinflammation and neurodegeneration in AD [33, 34] .
Hypothesis 1: Constitutive GILZ Regulates Physiological Aβ in CNS Health
The normal brain contains soluble, oligomerized, and aggregated Aβ. Picomolar concentration of Aβ exhibits neurotrophic properties, promotes neurogenesis, and contributes to normal synaptic activity and memory [35] . Mechanistically, physiological Aβ mediates tyrosine phosphorylation and increases phosphatidylinositol-3-kinases (PI3K) activity in neuronal cells [22, 36, 37] . The PI3K pathway has been implicated in modulating autophagy, neuronal survival, neurite extension, and synaptic plasticity in the brain. Blockade of this pathway increased apoptosis in Aβ exposed neuronal cells [38, 39] .
As stated above, considerable data suggest essential roles for MR, the high-affinity receptor for glucocorticoids, in neuronal survival and neurogenesis [10] . In health, under low GC condition, ligand-activated MR has been shown not only to induce BACE1 transcription and inflammatory cytokines that facilitate Aβ production, but also to upregulate many neuroprotective molecules [4, 40] . In PC12 neuronal cells, overexpression of MR enhanced neuron-specific genes such as MAP2 and β-tubulin III, increased the ratio of anti-apoptotic (Bcl2 and Bcl xL ) to pro-apoptotic (Bax and Bak) proteins, and diminished caspase-3 cleavage [41, 42] . While exposure to Aβ reduced MR expression and increased nuclear GR in cultured rat hippocampal and cortical neurons with a consequent increase in cell death, activation of MR reduced the vulnerability of the cultured neurons to apoptosis [42, 43] . Tauroursodeoxycholic acid (TUDCA) and cholesterol-derived endogenous molecule mediated neuroprotective effects by selectively activating MR with subsequent transactivation of Bcl-2 and other anti-apoptotic genes [44] . It has been suggested that an optimal balance between MR and GR activation with MR predominating in the hippocampus is necessary for the best emotional and cognitive function [1, 10, 11] .
GILZ is one of the transcripts upregulated by both MR and GR [33, 45] . Mechanistically, much like glucocorticoids, GILZ enhanced expressions of anti-apoptotic molecules including Bcl-2 and Bcl-XL in different cell types such as cardiomyocytes, epithelial cells, and many human cancer cells [33, [46] [47] [48] . GILZ has also been shown to modulate the PI3K pathway, suppress cytokines, and inhibit inflammation in activated lymphocytes and epithelial cells [49, 50] .
Extrapolating the molecular effects of GILZ on CNS cells, it is postulated that under physiological low GC conditions, constitutive GILZ may act in concert with picomolar Aβ in regulating autophagy and neuronal survival by increasing anti-apoptotic factors and suppressing excessive cytokines (Fig. 1) . Furthermore, since PI3K signaling has been shown to play critical roles in regulating survival of Aβ exposed neurons, it is tempting to speculate that the regulation of PI3K signaling by constitutive GILZ in neurons may indirectly control the threshold of Aβ accumulation and CNS health.
Hypothesis 2: GILZ Plays a Role in Neurogenesis
Neurogenesis involves proliferation, survival, migration, and lineage differentiation of neural stem/progenitor cells. Continuous stimulation, including cognitive activity, elicits protective responses that avoid tissue damage, promote neurogenesis, and maintain homeostasis in the CNS. This involves complex signaling pathways that are interlinked and tightly regulated [51] . Glucocorticoid and NF-κΒ signaling represent two cross-talking pathways shown to play crucial roles in adult neurogenesis [52, 53] . Physiological concentrations of glucocorticoid signaling via MR increased the proliferation and differentiation of human hippocampus-derived stem cells. In mice treatment with MR agonists increased the proliferation and reduced apoptosis leading to enhanced survival of adult neural progenitor cells [54, 55] . Furthermore, fludrocortisone, a strong selective MR agonist rescued Fig. 1 . Schematic representation of potential role of GILZ in regulating physiological amyloid beta (Aβ) in CNS. In healthy CNS, picomolar Aβ and low glucocorticoid concentration exhibit neurotrophic properties, promote neurogenesis, and contribute to normal synaptic activity and memory. Signaling via phosphatidylinositol-3-kinases (PI3K) is critical for the neuroprotective effects of picomolar (pM) Aβ. Since, mechanistically, the anti-inflammatory effect of GILZ has been attributed in part to the suppression of PI3K activity, this figure depicts a schematic plausibility of a role for MR-induced constitutive GILZ in modulating PI3K signaling and thereby indirectly regulating Aβ and neuronal survival. Higher (pathological) Aβ or glucocorticoid concentration activates NF-κB p65 or GR-mediated pro-apoptotic factors promoting neuronal cell death and degeneration hippocampal progenitor cells from Aβ-induced apoptosis [55] . Much like glucocorticoid signaling, physiological NF-κΒ signaling mediated by low concentrations of proinflammatory cytokines such as TNF-α or the excitatory neurotransmitter glutamate increases proliferation and differentiation of neural stem cells and promotes neuronal survival [52, 56] . It has been suggested that the neuroprotection is largely attributed to the activation of NF-κΒ C-rel dimers [57] [58] [59] .
As opposed to the protective effects of MR, treatment with dexamethasone, a high-affinity GR agonist suppressed phosphorylated ERK and inhibited proliferation of neural progenitor cells [60] . Similarly, as opposed to the protective effects of NF-κB C-rel activation in healthy CNS, neuroinflammation characterized by elevated phosphokinases, cytokines, and NF-κB p65 inhibits neural stem cells [52, 57, 58, [61] [62] [63] . Increased GR activation in mice subjected to acute immobilization or chronic unpredictable stress has been shown to reduce the proliferation of neural stem cells or amplifying progenitor cells. Significantly, the suppressive effect of the GR on stem cells was abrogated by pretreatment with NF-κB inhibitors [64, 65] .
Based on these observations, it is speculated that the GILZ at the interface of GC and NF-κB p65 could play a role in modulating the neural stem cell responses and neurogenesis (Fig. 2) . A balance between the MR-induced GILZ by endogenous glucocorticoids and constitutive NF-κB in healthy CNS may promote neural cell proliferation and survival. Inhibition of GILZ by perturbation of this balance either by excessive stress or neuroinflammation could contribute to the increased susceptibility of neural stem cells to apoptosis.
In addition to NF-κΒ, GILZ also interacts with other transcription factors such as PPAR-γ and C/EBP-δ, implicated in adult neurogenesis [66, 67] . Basal expression of both C/EBPδ and PPAR-γ in adult CNS is relatively low [68, 69] . While NF-κΒ activation and cytokines such as TNF-α enhance C/ EBPδ expression, sustained elevation of inflammatory cytokines suppresses its transcription [70] . In addition to GILZ, glucocorticoids also enhance transcription of both C/EBPδ and PPAR-γ [71, 72] . C/EBPδ in turn binds the C/EBPbinding elements in PPAR-γ promoter and upregulate its transcription [69, 70] . Several reports substantiate a neurogenic role for PPAR-γ. Activation of PPAR-γ promotes differentiation of neural stem cells to mature neurons, astrocytes, and oligodendrocytes [68] . Furthermore, treatment with PPAR-γ agonists induced neurite outgrowth and increased axonal length in hippocampal neurons [73] .
In contrast to C/EBPδ, GILZ has been shown to bind a tandem repeat of C/EBP-binding sites in the promoter region and act as a sequence-specific trans-repressor of PPAR-γ in pluripotent mouse mesenchymal stem cells [32] . In human, bone marrow-derived stem cell dexamethasone-induced GILZ suppressed PPAR-γ2 and upregulated RUNX-2 transcription factor [67, 74] . Although a plethora of studies substantiates the critical involvement of RUNX2 in osteogenesis, few reports suggest a potential role for the molecule in neuronal development [75] [76] [77] . Adult human hippocampus and Fig. 2 . Schematic representation of a potential role for GILZ in adult neurogenesis. Toll like receptor (TLR) stimulation and cytokines such as TNF-α activate NF-κB transcription factor in adult hippocampal neural stem cells. While NF-κB C-rel containing dimers are predominantly neuroprotective, p65-containing dimers promote inflammatory cytokines that upregulate C/EBPδ and PPAR-γ transcription factors. Activated PPAR-γ promotes differentiation of neural stem cells to mature neurons, astrocytes, and oligodendrocytes. Glucocorticoids induced GILZ transrepresses PPAR-γ and increase transactivation of RUNX-2. Elevated RUNX-2 is inversely related to NF-κΒ p65. GILZ can potentially contribute to neurogenesis by inhibiting NF-κB p65 and upregulating RUNX-2 transcription cultured rat astrocytes have been shown to express RUNX2 transcript [76, 77] . In human astroglioma cells, RUNX2 is significantly elevated and regulates the expression of galectin 3, a soluble β-galactoside-binding lectin known to promote neural cell adhesion and neurite growth [77] .
Collectively, the physical interactions of GILZ with multiple transcription factors greatly enhance the number of potentially regulated genes or post-translational modifications that could crucially affect molecular mechanisms involved in the dynamic process of adult neurogenesis. It could be postulated that under low glucocorticoid and inflammatory conditions, GILZ could facilitate neuronal differentiation of stem cells and promote hippocampal neurogenesis by upregulating RUNX-2 transcription. This is supported by observations of the inverse relationship between NF-κΒ and RUNX-2 transcription factors and elevated RUNX-2 in adult hippocampus [77, 78] .
Hypothesis 3: Exogenous GILZ Is an Attractive Strategy to Suppress Neuroinflammation
Neuroinflammation plays critical roles in the initiation and/or progression of pathology in most neurodegenerative diseases including AD [79] [80] [81] . Aging and chronic stress are significant risk factors. Elevated glucocorticoids due to persistent stress enhance neuronal cell vulnerability to glutamate and Aβ-induced neurotoxicity [1, 19] . Aβ exposure activates p65:p50 NF-κΒ dimers in glia and post-mitotic neurons and enhances transactivation of inflammatory and pro-apoptotic genes [82] . Increased Bax (proapoptotic) to Bcl-2 (anti-apoptotic) ratio has been observed in Aβ-stimulated neuronal cells [83] [84] [85] . Elevated IL-1β, IL-6, and TNF-α are reported in the affected tissues, serum, and CSF of AD patients [86] . However, exogenous glucocorticoids, the prototype anti-inflammatory agents have been largely ineffective and even counter-productive in the treatment of AD. The low therapeutic efficacy of glucocorticoids is correlated with a disproportionate increase in the glucocorticoid:GR complex with enhanced susceptibility to apoptosis [87] .
GILZ represents a potentially efficacious alternative antiinflammatory molecule to suppress neuroinflammation (Fig. 3) . Mechanistically, the anti-inflammatory and anti-apoptotic effects of both glucocorticoids and GILZ are largely attributed to suppression of NF-κΒ-mediated transactivation [65, 88] . While the glucocorticoid:GR complex tether to and interferes with NF-κΒ-DNA binding, GILZ binds to and sequesters the p65 subunit of NF-κΒ in the cytoplasm, thereby preventing its nuclear translocation and consequent transactivation of pathological mediators [7, 26, 89] . Structurally, the proline-rich region of GILZ binds the transactivation domain of p65 exposed following its release from IκB inhibitory complex in activated cells [26, 89] . Overexpression of GILZ suppressed inflammatory cytokines and ameliorated pathology in models of colitis, multiple sclerosis, and spinal cord injury [34, 90, 91] . Recombinant human GILZ protein or organic derivatives of the functional domain of GILZ can exert similar suppressive effects and serve as potential therapeutics for neuroinflammation [92, 93] . We observed that selective blockade of activated p65 by a synthetic peptide mimic of the p65-binding domain of GILZ suppressed Aβ-mediated toxicity in neuroblastoma cells and in primary human neuronal cells [93, 94] . Taken together, it is hypothesized that by virtue of binding the transactivation domain of p65 exposed only in activated cells, exogenous GILZ represents an attractive strategy to suppress neuroinflammatory-neurodegenerative diseases including AD (Fig. 3) .
Conclusion
The effects of endogenous and exogenous glucocorticoids in neurogenesis, neuroinflammation, and neurodegeneration in the CNS have been extensively investigated with some mechanistic elucidations, some contradictory findings and some as yet unanswered questions. It is tempting to speculate that some of the contradictory or unknown glucocorticoid effects could be attributed to GILZ expression. The uneven distribution and upregulated expression following HPA activation suggest multiple roles for GILZ in the CNS. Much like its effects on osteogenic differentiation, GILZ could potentially play a role in neuronal differentiation and development. In microglial cells, a tightly controlled and coordinated action of MR and GR has been shown to regulate NF-κΒ functions Fig. 3 . Schematic representation of exogenous GILZ as a potential therapeutic agent for AD. Aging, chronic stress, amyloid β (Aβ) aggregates or other factors mediated oxidative stress activate NF-κB p65 which in turn induces activation of pro-inflammatory (cytokines, glutamate) and pro-apoptotic factors that ultimately lead to cell death. Exogenous GILZ or GILZ analogs will bind NF-κB p65 and prevent activation of deleterious mediators [8] . At low ligand concentration or at early time points following activation, the effects of MR-mediated transactivation of neurotrophic factors and anti-inflammatory GILZ could potentially supersede that of BACE1 and pro-inflammatory cytokines. In conditions of chronic stress and/or Aβ toxicity, inflammatory mediators suppress GILZ. In this context, exogenous GILZ could represent an attractive strategy to suppress neuroinflammation. In conclusion, elucidation of the physiological role of GILZ in the CNS, its induction by other factors including microbial agents or free radicals, role in BACE1 activity, and Aβ homeostasis will enhance our understanding of the glucocorticoid signaling in the CNS and help in the identification of alternative therapeutic strategies to target neuroinflammation and neurodegeneration.
